A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease

Virology

Volumn 234, Issue 2, 1997, Pages 261-266

  Campo, M Saveria ^a   O'Neil, Brian W ^b   Grindlay, G Joan ^a   Curtis, Fiona ^a   Knowles, Graham ^a   Chandrachud, Lata ^b  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b Department of Veterinary Pathology ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; KEYHOLE LIMPET HEMOCYANIN; NEUTRALIZING ANTIBODY; SYNTHETIC PEPTIDE; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; VIRUS CARCINOGENESIS; VIRUS INFECTION;

ANIMALIA; BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 4; BOVINE PARVOVIRUS; MIRIDAE; PAPILLOMAVIRUS;

EID: 0030790229     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8649     Document Type: Article

References (27)

1. Breitburd F., Kirnbauer R., Hubbert N. L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G., Schiller J. T., Lowy D. R. Immunization with virus-like particles from cottontail papillomavirus can protect against experimental CRPV infection. J. Virol. 69:1995;3959-3963.
2. Campo M. S. Vaccination against papillomavirus in cattle. Current Topics in Microbiology and Immunology. 1994;. p. 255-266.
3. Campo M. S. Bovine papillomavirus and cancer. Vet. J. 1997.
4. Campo M. S., Jarrett W. F. H. Vaccination against cutaneous and mucosal papillomavirus in cattle. Ciba Found. Symp. 187:1994;61-72.
5. Campo M. S., Grindlay G. J., O'Neil B. W., Chandrachud L. M., McGarvie G. M., Jarrett W. F. H. Prophylactic and therapeutic vaccination against a mucosal papillomavirus. J. Gen. Virol. 74:1993;945-953.
6. Chandrachud L. M., Grindlay G. J., McGarvie G. M., O'Neil B. W., Wagner E. R., Jarrett W. F. H., Campo M. S. Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for prevention of infection by bovine papillomavirus type 4. Virology. 211:1995;204-208.
7. Chen L., Thomas E. K., Hu S-L., Hellstrom I., Hellstrom K. E. Human papillomavirus type 16 nucleoprotein E7 is a tumour rejection antigen. Proc. Natl. Acad. Sci. USA. 88:1991;110-114.
8. Christensen N. D., Kreider J. W., Kan N. C., DiAngelo S. L. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes. Virology. 181:1991;572-579.
9. Christensen N. D., Reed C. A., Cladel N. M., Han R., Kreider J. W. Immunization with virus-like particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J. Virol. 70:1996;960-965.
10. Feltkamp M. C. W., Smits H. L., Vierboom M. P. M., Minnaar R. P., de Jongh B. M., Drijfhout J. W., ter Schegget J., Melief C. J. M., Kast W. M. Vaccination with cytotoxic T-lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23:1993;2242-2249.
11. Gaukroger J. M., Chandrachud L. M., O'Neil B. W., Grindlay G. J., Knowles G., Campo M. S. Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. J. Gen. Virol. 77:1996;1577-1583.
12. Human Papillomaviruses. 64:1995.
13. Jarrett W. F. H. The natural history of bovine papillomavirus infection. Adv. Viral Oncol. 5:1985;83-101.
14. Kirnbauer R., Chandrachud L. M., O'Neil B. W., Wagner E. R., Grindlay G. J., Armstrong A., McGarvie G. M., Schiller J. T., Lowy D. R., Campo M. S. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology. 219:1996;37-44.
15. Knowles G., Chandrachud L. M., O'Neil B. W., Grindlay G. J., Campo M. S. Linear B-cell epitopes in the N-terminus of L2 of bovine papillomavirus type 4. Res. Vet. Sci. 62:1997.
16. Knowles G., O'Neil B. W., Campo M. S. Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J. Virol. 70:1996;8451-8458.
17. Lin Y-L., Borenstein L. A., Selvakumar R., Ahmed R., Wettstein F. O. Effective vaccination against papilloma development by immunization with L1 or L2 structural proteins of cottontail rabbit papillomavirus. Virology. 187:1992;612-619.
18. Lin Y-L., Borenstein L. A., Ahmed R., Wettstein F. O. Cottontail Rabbit papillomavirus L1 protein-based vaccines: Protection is achieved only with a full length non denatured product. J. Virol. 67:1993;4154-4162.
19. Liu W. J., Gissmann L., Sun X. Y., Kanjanahaluethai A., Muller M., Doorbar J., Zhou J. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology. 227:1997;474-483.
20. McLean C. S., Sterling J. S., Mowat J., Nash A. A., Stanley M. A. Delayed type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. J. Gen. Virol. 74:1993;239-245.
21. Meneguzzi G., Cerni C., Kieny M. P., Lathe R. Immunization against human papillomavirus type 16 tumour cells with recombinant vaccinia virus expressing E6 and E7. Virology. 181:1991;62-69.
22. Menne S., Maschke J., Tolle T. K., Lu M., Roggendorf M. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing T-cell epitope. J. Virol. 71:1997;65-74.
23. Parkin S. M., Laara E., Muir C. Estimates of the worldwide frequency of 16 major cancers in 1980. Int. J. Cancer. 41:1988;184-197.
24. Roden R. B. S., Weissinger E. M., Henderson D. W., Booy F., Kirnbauer R., Mushinski F., Lowy D. R., Schiller J. T. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 68:1994;7570-7574.
25. Volpers C., Sapp M., Komly C. A., Richalet-Secordel P., Streeck R. E. Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33. J. Virol. 67:1993;1927-1935.
26. Yaegashi N., Jenison S. A., Batra M., Galloway D. A. Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus 6 and 11. J. Virol. 66:1992;2008-2019.
27. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Current Topics in Microbiology and Immunology. 1994;. p. 131-156.